Summary
This article explores the possibility that malfunction of the enzyme monoamine oxidase (E.C. 1.4.3.4., MAO) could lead to aberrations in the catabolism of biogenic amines in the central nervous system and give rise to certain mental abnormalities. No conclusive evidence could be presented to substantiate this. Data on the normal function of the enzyme (for example its existence in multiple forms, the control of MAO activity by hormones or the independent development of MAO activities towards different substrates during maturation) are reviewed.
Similar content being viewed by others
References
Anselmi, R., Bufjoni, F., Curradi, C., Del Bianco, P. L., Sicuteri, F.: Monoamine oxidase defect in essential arterial hypertension: a single dose pargyline test. Br. J. Pharmac.52, 460 P (1974).
Arnaiz, G. R. de L., de Robertis, E. D. P.: Cholinergic and noncholinergic nerve endings in the rat. II. Subcellular localization of monoamine oxidase and succinate dehydrogenase. J. Neurochem.9, 503–508 (1962).
Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., Mac Dougall, E., Stanton, J. B., Binns, J. K.: 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet2, 1049–1052 (1966).
Ashcroft, G. W., Sharman, D. F.: 5-Hydroxyindoles in human cerebrospinal fluids. Nature (Lond.)186, 303–305 (1960).
Avakian, V. M., Callingham, B. A.: An effect of adrenalectomy upon catecholamine metabolism. Br. J. Pharmac. Chemother.33, 211–212 P (1968).
Bakhle, Y. S., Youdim, M. B. H.: Inactivation of phenylethylamine and 5-hydroxytryptamine in rat isolated lungs: evidence for monoamine oxidase A and B in lung. J. Physiol. (Lond.)248, 23–25 P (1975).
Bakhle, Y. S., Youdim, M. B. H.: Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase “type B” in lung. Br. J. Pharmac.56, 125–127 (1976).
Belmaker, R. H., Murphy, D. L., Wyatt, R. J., Loriaux, D. L.: Human platelet monoamine oxidase changes during the menstrual cycle. Arch. Gen. Psychiat.31, 553–556 (1974).
Bennett, D. S., Giarman, N. J.: Schedule of appearance of 5-hydroxytryptamine (serotonin) and associated enzymes in the developing rat brain. J. Neurochem.12, 911–918 (1965).
Bernheimer, H., Birkmayer, W., Hornykiewicz, O.: Homovanillinsäure im Liquor cerebrospinalis: Untersuchungen beim Parkinson-Syndrom und anderen Erkrankungen des ZNS. Wien. klin. Wschr.78, 417–419(1966).
Bernheimer, H., Birkmayer, W., Hornykiewicz, O.: Verhalten der Monoaminoxydase im Gehirn des Menschen nach Therapie mit Monoaminoxidase-Hemmern. Wiener klin. Wschr.74, 558–559 (1962).
Birkmayer, W., Hornykiewicz, O.: Der Dioxyphenylalanin (L-Dopa) Effekt beim Parkinson-Syndrom des Menschen. Arch. Psych.203, 560–571 (1962).
Birkmayer, W., Riederer, P., Youdim, M. B. H., Linauer, W.: The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of MAO-B, Deprenil. J. Neural Transmission36, 303–326 (1975).
Bhagat, B, Bryan, R. J., Lee, Y. C.: Increase in adrenal monoamine oxidase in hypophysectomized rats after ACTH. Neuropharmacol.12, 1199 to 1202 (1973).
Blaschko, H.: The natural history of amine oxidase. Rev. Physiol. Biochem. Pharmacol.70, 84–148 (1974).
Blatchford, D., Grahame-Smith, D. G., Holzbauer, M., Youdim, M. B. H.: Ontogenesis of enzyme systems deaminating different monoamines. Br. J. Pharmac., in press (1976).
Blatchford, D., Holzhauer, M., Youdim, M. B. H.: Substrate and strain differences in the development of brain monoamine oxidase. Br. J. Pharmac.54, 251 P (1975).
Bloom, F. E., Giarman, N. J.: Physiologic and pharmacologie consideration of biogenic amines in the nervous system. Ann. Rev. Pharmacol.8, 229–247 (1969).
Boadle, M. C., Bloom, F. E.: A method for the fine structural localization of monoamine oxidase. J. Histochem. Cytochem.17, 331–340 (1969).
Bourne, H. R., Bunney, W. E., Jr., Colburn, R. W., Davis, J. M., Davis, J. N., Shaw, D. M., Coppen, A. J.: Noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole acetic acid in hindbrains of suicidal patients. LancetII, 805 (1968).
Bulat, M., Zivković, B.: Origin of 5-hydroxyindoleacetic acid in the spinal fluid. Science173, 738–740 (1971).
Callingham, B. A., Della Corte, L.: Effect of adrenalectomy upon some rat heart enzymes. Br. J. Pharmac.41, 392 P (1971).
Ceasar, P. M., Collins, G. G. S., Sandler, M.: Catecholamine metabolism and monoamine oxidase activity in adrenalectomized rats. Biochem. Pharmac.19, 921–926 (1970).
Clarke, D. E., Moonat, L. S.: L-Thyroxine (T4) and organ monoamine oxidase (MAO) activity. Abstr. Sixth Internat. Congr. Pharmacol., Helsinki, p. 107 (1975).
Clarke, D. E., Sampath, S. S.: Effect of hypophysectomy, bilateral adrenalectomy and hormone replacement therapy upon organ monoamine oxidase activity. Experientia31, 1098–1100 (1975).
Cohen, S., Bitensky, L., Chayen, J.: The study of monoamine oxidase by histochemical procedures. Biochem. Pharmac.14, 223–226 (1965).
Cohen, S., Bitensky, L., Chayen, J., Cunningham, G. J., Russel, J. K.: Histochemical studies on the human endometrium. Lancet2, 56–59 (1964).
Coleman, M.: Serotonin and central nervous system syndromes of childhood: A review. J. Aut. Child. Schizo.3, 27–36 (1973).
Collins, G. G. S., Pryse-Davies, J., Sandler, M., Sonthgate, J.: Effect of pretreatment with oestradiol, progesterone and Dopa on monoamine oxidase activity in the rat. Nature (Lond.)226, 642–643 (1970).
Collins, G. G. S., Sandler, M.: Human blood platelet monoamine oxidase. Biochem. Pharmac.20, 289–296 (1971).
Collins, G. G. S., Sandler, M., Williams, E. D., Youdim, M. B. H.: Multiple forms of human brain mitochondrial monoamine oxidase. Nature (Lond.)225, 817–820 (1970).
Costa, E., Gessa, G. L., Sandler, M.: Serotonin—New vistas. Histochemistry and pharmacology (Adv. Biochem. Psychopharmacol., Vol. 10). New York: Raven Press. 1974 a.
Costa, E., Gessa, G. L., Sandler, M.: Serotonin—New vistas. Biochemistry and behavioral and clinical studies (Adv. Biochem. Psychopharmacol., Vol. 11). New York: Raven Press. 1974 b.
Crow, T. J., Johnstone, E. C., Owen, F. R.: An investigation of platelet monoamine oxidase activity in schizophrenia. In: Monoamine oxidase and its inhibition (Knight, J., ed.). Amsterdam: North Holland. In press (1976).
Davis, A. J., Holzbauer, M., Sharman, D. F., Youdim, M. B. H.: Postnatal development of dopamine deamination in the striatum of the rat. Br. J. Pharmac.55, 558–560 (1975).
Dencker, S. J., Malm, U., Roos, B.-E., Werdinius, B.: Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J. Neurochem.13, 1545–1548 (1966).
Diaz Borges, J. M., D'Iorio, A.: Polyacrylamide gel electrophoresis of rat liver mitochondrial monoamine oxidase. Can. J. Biochem.51, 1089 to 1095 (1973).
Domino, E. F., Krause, R. R., Bowers, J.: Various enzymes involved with putative neurotransmitters. Arch. Gen. Psychiat.29, 195–201 (1973).
Ernster, L., Kuylenstierna, B.: Structure, composition and function of mitochondrial membranes. In: Mitochondria—structure and function (Ernster, L., Drahota, Z., eds.), pp. 5–31. London: Academic Press. 1969.
Feldstein, M., Hoagland, H., Wong, K. K.-K., Oktem, M. R., Freeman, H.: MAO activity in relation to depression. Am. J. Psychiat.120, 1192 to 1194 (1964).
Friedman, E., Shopsin, B., Sathananthan, G., Gershon, S.: Blood platelet monoamine oxidase activity in psychiatric patients. Am. J. Psychiat.131, 1942–1494 (1974).
Ghose, K., Turner, P., Coppen, A.: Intravenous tyramine pressor response in depression. LancetII, 1317–1318 (1975).
Glick, D., Greenberg, L. J.: The quantitative histological distribution of the succinic dehydrogenase system in the rat adrenal and the influence of hypophysectomy, ACTH and cortisone. Endocrinology63, 778–784 (1958).
Gorkin, V. Z.: Partial separation of rat liver mitochondrial amine oxidases. Nature (Lond.)200, 77 (1963).
Gorkin, V. Z.: Monoamine oxidases. Pharmac. Rev.18, 115–120 (1966).
Gottfries, C. G., Oreland, L., Wiberg, A., Winblad, B.: Brain levels of monoamine oxidase in depression. LancetII, 360–361 (1974).
Gottfries, C. G., Oreland, L., Wiberg, A., Winblad, B.: Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem.25, 667–674 (1975).
Green, A. R., Grahame-Smith, D. G.: 5-Hydroxyindoleamine and other indoles in the central nervous system. In: Handbook of Psychopharmacology Vol. 3 (Iversen, L. L., Iversen, S., Snyder, S., eds.), pp. 169 to 245. New York: Plenum Press. 1975.
Green, D. E., Allmann, D. W., Harris, R. A., Tan, W. C.: Enzyme localization in the inner and outer mitochondrial membranes. Biochem. Biophys. Res. Commun.31, 368–378 (1968).
Greenawalt, J. W., Schnaitman, C.: An appraisal of the use of monoamine oxidase as an enzyme marker for the outer membrane of rat liver mitochondria. J. Cell Biol.46, 173–179 (1970).
Hartman, B. K.: The discovery and isolation of a new monoamine oxidase from brain. Biol. Psychiat.4, 147–155 (1972).
Hartman, B. K., Udenfriend, S.: The application of immunologicai techniques to the study of enzymes regulating catecholamine synthesis and degradation. Pharmac. Rev.24, 311–330 (1972 a).
Hartman, B. K., Udenfriend, S.: The use of an immunologicai technique for the characterization of bovine monoamine oxidase from liver and brain. Adv. Biochem. Psychopharmacol.5, 119–128 (1972 b).
Hawkins, J.: The localization of amine oxidase in the liver cell. Biochem. J.50, 577–581 (1952).
Heller, B., Narasimhachari, N., Spaide, J., Haskovec, L., Himwich, H. E.: N-dimethylated indoleamines in blood of acute schizophrenics. Experientia26, 503–504 (1970).
Hidaka, H., Hartman, B., Udenfriend, S.: Comparison of mitochondrial monoamines oxidase from bovine brain and liver using antibody to purified liver monoamine oxidase. Arch. Biochem.147, 805–809 (1971).
Hidaka, H., Nagatsu, T., Nagasaka, A., Ishizuki, Y.: Monoamine oxidase activity in the thyroid glands in thyroid disease. Clin. Chim. Acta23, 383–386 (1969).
Holzbauer, M., Bull, G., Youdim, M. B. H., Wooding, F. B. P., Godden, U.: Subcellular distribution of steroids in the adrenal gland. Nature, New Biol.242, 117–119(1972).
Holzbauer, M., Mitchell, B., Youdim, M. B. H.: Effect of hypophysectomy on tissue MAO activity. In: Catecholamines and stress, pp. 321–330 (Usdin, E., Kvetňaský, R., Kopin, I. J., eds.). Pergamon Press Oxford. 1976.
Holzbauer, M., Youdim, M. B. H.: The influence of endocrine glands on the central and peripheral monoamine oxidase activity. Br. J. Pharmac.44, 355 P (1972).
Holzbauer, M., Youdim, M. B. H.: The oestrous cycle and monoamine oxidase activity. Br. J. Pharmac.48, 600–608 (1973).
Horita, A.: Cardiac monoamine oxidase in rat. Nature (Lond.)215, 411 to 412 (1967).
Horita, A.: The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition. Biochem. Pharmac.17, 2091–2096 (1968).
Houslay, M. D., Tipton, K. F.: The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidase. Biochem. J.135, 173–186(1973).
Houslay, M. D., Tipton, K. F.: A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membrane. Biochem. J.139, 645–652 (1974).
Ho-Van-Hap, A., Babineau, L. M., Berlinguet, L.: Hormonal action on monoamine oxidase activity in rats. Can. J. Biochem.45, 355–362 (1967).
Iversen, L. L.: Catecholamine uptake processes. Brit. Med. Bull.29, 130 to 135 (1973).
Johnston, J. P.: Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmac.17, 1285–1297 (1968).
Jepson, J. B.: Hartnup disease. In: The metabolic basis of inherited disease (Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., eds.), pp. 1486 to 1503. New York: McGraw-Hill. 1972.
Karki, N., Kuntzman, R., Brodle, B. B.: Storage, synthesis and metabolism of monoamines in the developing brain. J. Neurochem.9, 53–58 (1962).
Knoll, J., Magyar, K.: Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol.5, 393–408 (1972).
Knox, W. E.: Phenylketonuria. In: The metabolic basis of inherited disease (Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., eds.), pp. 266 to 295. New York: McGraw-Hill. 1972.
Kopin, I. J.: Storage and metabolism of catecholamines. The role of monoamine oxidase. Pharmac. Rev.16, 179–191 (1964).
Kroon, M. C., Veldstra, H.: Multiple forms of rat brain mitochondrial monoamine oxidase: subcellular localization. FEBS Letters24, 173–177 (1972).
Kurzepa, S., Bojanek, J.: The 5-HT level and monoamine oxidase activity in rat brain during development. Biol. Neonat.8, 216–221 (1965).
Levene, R. J., Oates, J. A., Vendsalu, A., Sjoerdsma, A.: Studies on the metabolism of aromatic amines in relation to altered thyroid function in man. J. clin. Endocr. Metab.22, 1242–1250 (1962).
Lloyd, K. G., Davidson, L., Hornykiewicz, O.: The neurochemistry of Parkinson's disease: effect of L-Dopa therapy. J. Pharmac. exp. Ther.195, 453–464 (1975).
Lyles, G. A., Callingham, B. A.: The effect of thyroid hormones on monoamine oxidase in the rat heart. J. Pharm. Pharmac.26, 921–930 (1974).
McCauley, R., Racker, E.: Separation of two monoamine oxidases from bovine brain. Mol. Cell. Biochem.1, 73–81 (1973).
Marchbanks, R. M.: Serotonin binding to nerve ending particles and other preparations from rat brain. J. Neurochem.13, 1481–1483 (1966).
Meltzer, H. Y., Stahl, S. M.: Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients. Res. Commun. Chem. Path. Pharmacol.7, 419–431 (1974).
Miller, R. A.: The relation of mitochondria to secretory activity in the fascicular zone of the rat's adrenal. Am. J. Anat.92, 329–360 (1953).
Moir, A. T. B., Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Guldberg, H. C.: Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain93, 357–368 (1970).
Murphy, D. L., Donnelly, C. H.: Monoamine oxidase in man: enzyme characteristics in platelets, plasma and other human tissues. Adv. Biochem. Psychopharmacol.12, 71–86 (1974).
Murphy, D. L., Weiss, R.: Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Am. J. Psychiat.128, 1351–1357 (1972).
Murphy, D. L., Wyatt, R. J.: Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature (Lond.)238, 225 to 226 (1972).
Neff, N. H., Yang, H. Y.: Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Life Sei. Oxford14, 2061–2074 (1974).
Neff, N. H., Yang, H. Y., Fuentes, J. A.: The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain. Adv. Biochem. Psychopharmacol.12, 49–58 (1974).
Nies, A., Robinson, D. S.: Monoamine oxidase activity in human. In: Modern problems of pharmacopsychiatry: genetics and psychopharmacology (Mendlewicz, J., ed.), pp. 89–111. Basel: Karger. 1975.
Nies, A., Robinson, D. S., Harris, L. S., Lamborn, K. R.: Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives and controls. Adv. Biochem. Psychopharmacol.12, 59–85 (1974).
Nies, A., Robinson, D. S., Lamborn, K. R., Lampert, R. P.: Genetic control of platelet and plasma monoamine oxidase activity. Arch. gen. Psychiat.28, 834–838 (1973).
Nies, A., Robinson, D. S., Ravaris, C. L., Davis, J. M.: Amines and monoamine oxidase in relation to aging and depression in man. Psychosom. Med.33, 470(1971).
Novick, W. J.: The effect of age and thyroid hormones on the monoamine oxidase of rat heart. Endocrinology69, 55–59 (1961).
Okamoto, H.: Influence of L-thyroxine on kynurenine 3-hydroxylase, monoamine oxidase and rotenone-insensitive NADH2-cytochrome C reductase in mitochondrial outer membrane. Biochem. Biophys. Res. Commun.43, 827–833 (1971).
Okamoto, H., Yamamoto, S., Nozaki, M., Hyashi, O.: On the submitochondrial localization of L-kynurenine-5-hydroxylase. Biochem. Biophys. Res. Commun.26, 309–314 (1967).
O'Malley, B. W., Schrader, W. T.: Progesterone receptor components: identification of subunits binding to the target-cell genome. J. Steroid Biochem.3, 617–629 (1972).
Papeschi, R., McClure, D. J.: Homovanillic acid and 5-hydroxyindole acetic acid in cerebrospinal fluid of depressed patients. Arch. gen. Psychiat.25, 354–358 (1971).
Pare, C. M. B., Sandler, M.: A clinical and biochemical study of a trial of iproniazid in the treatment of depression. Neurol. Neurosurg. Psychiat.22, 247–251 (1959).
Parvez, H., Parvez, S.: The effect of metopirone and adrenalectomy on the regulation of the enzymes monoamine oxidase and catechol-O-methyl transferase in different brain regions. J. Neurochem.20, 1011–1020 (1973).
Parvez, H., Parvez, S., Youdim, M. B. H.: Variation in activity of monoamine metabolizing enzymes in rat liver during pregnancy. Br. J. Pharmac.53, 241–246.
Pohorecky, L. A., Bagila, B. S., Wurtman, R. J., Banter, F. C.: Adrenocortical control of catecholamine metabolism in the dog adrenal medulla: relationship to protein synthesis. Endocrinology93, 566–574 (1973).
Praag, van, H. M., Korf, J., Puite, J.: 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature (Lond.)225, 1259–1260 (1970).
Pugh, C. E. M., Quastel, J. M.: Oxidation of aliphatic amines by brain and other tissues. Biochem. J.31, 286–291 (1937).
Racker, E., Proctor, H.: Reconstitution of the outer mitochondrial membrane with monoamine oxidase. Biochem. Biophys. Res. Commun.39, 1120 to 1125 (1970).
Robinson, D. S., Davis, J. M., Nies, A., Colburn, R.W., Davis, J. N., Bourne, H. R., Bunney, W. E., Shaw, D. M., Coppen, A.-J.: Ageing, monoamines and monoamine oxidase. LancetI, 290–291 (1972).
Robinson, D. S., Nies, A.: Genetics of monoamine oxidase. In: Genetics and psychopharmacology (Mod. Probl. Pharmacopsych. Vol. 10) (Mendlewicz, J., ed.), pp. 57–64. Basel: Karger. 1975.
Ruhmann-Wennhold, A., Nelson, D. H.: Corticosteroidogenesis and its relation to ACTH dependence of mitochondrial components. Endocrinology93, 977–982 (1973).
Sampath, S., Clarke, D. E.: A specific increase in intraneuronal monoamine oxidase activity in the rat vas deferens following adrenalectomy. Life Sci. Oxford11, 1037–1048 (1972).
Sandler, M., Baidock, E.: In vivo monoamine oxidase activity in toxaemia of pregnancy. J. Obstet. Gynaec. Br. Commonw.70, 279–283 (1963).
Sandler, M., Bonham Carter, S., Cuthbert, M. T., Pare, C. M. B.: Is there an increase in monoamine oxidase activity in depressive illness? LancetII, 1045–1047 (1975).
Sandler, M., Bonham Carter, S., Pare, C. M. B.: Variations in monoamine oxidase activity in some human disease states. In: Monoamine oxidase and its inhibition (Knight, J., ed.). Amsterdam: North Holland. In press (1976).
Sandler, M., Conveney, J.: Placental monoamine oxidase activity in toxaemia of pregnancy. LancetI, 1096–1098 (1962).
Sandler, M., Youdim, M. B. H.: Multiple forms of monoamine oxidase: functional significance. Pharmac. Rev.24, 331–348 (1972).
Sandler, M., Youdim, M. B. H., Hanington, E.: A phenylethylamine oxidising defect in migraine. Nature (Lond.)250, 335–337 (1974).
Scheinberg, I. H., Sternlieb, I., Richman, J.: Psychiatrie manifestations in patients with Wilson's disease. In: Birth defects. Original article series4, 85–107(1968).
Schnaitman, L., Erwin, V. G., Greenawalt, J. W.: The submitochondrial localization of monoamine oxidase. J. Cell Biol.32, 719–735 (1967).
Schwartz, M. A., Aikens, A. M., Wyatt, R. J.: Monoamine oxidase activity in brains from schizophrenic and mentally normal individuals. Psychopharmacologia38, 319–328 (1974).
Severina, I. S.: The effect of alcohol on mitochondrial monoamine oxidase activity. Biull. Eksp. Biol. Med.79, 31–34 (1975).
Shaskan, E. G., Beckor, R. E.: Platelet monoamine oxidase in schizophrenics. Nature (Lond.)253, 659–660 (1975).
Shaw, D. M., Camps, F. E., Eccleston, E. G.: 5-Hydroxytryptamine in the hind brain of depressive suicides. Br. J. Psychiat.113, 1407–1411 (1967).
Silberstein, S. D., Shein, H. M., Berv, K. R.: Catechol-O-methyl transferase and monoamine oxidase activity in cultured rodent astrocytoma cells. Brain Res.41, 245–248 (1972).
Sjöström, R.: 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic depressive psychosis and the effect of probenecid treatment. Europ. J. Clin. Pharmacol.6, 75–80 (1973).
Sjöström, R., Roos, B.-E.: 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic depressive psychosis. Europ. J. Clin. Pharmacol.4, 170–176 (1972).
Southgate, J., Grant, E. C. G., Pollard, W., Pryse-Davis, J., Sandler, M.: Cyclic variation in endometrial monoamine oxidase: correlation of histochemical and quantitative biochemical assays. Biochem. Pharmac.17, 721–726 (1968).
Spector, S., Tarver, J., Berkowitz, B.: Effects of drugs and physiological factors in the disposition of catecholamines in blood vessels. Pharmac. Rev.24, 191–202 (1972).
Spinks, A., Burn, J. H.: Thyroid activity and amine oxidase in liver. Br. J. Pharmac. Chemother.7, 93–98 (1962).
Symes, A. L., Missala, K., Sourkes, T. L.: Iron and riboflavin dependent metabolism of a monoamine in the ratin vivo. Science174, 153–155 (1971).
Symes, A. L., Sourkes, T. L., Youdim, M. B. H., Gregoriadis, G., Birnbaum, H.: Decreased monoamine oxidase activity in liver of iron deficient rats. Can. J. Biochem.47, 999–1003 (1969).
Tipton, K. F.: The submitochondrial localization of monoamine oxidase in rat liver and brain. Biochim. Biophys. Acta135, 910–920 (1967).
Tipton, K. F.: Biochemical aspects of monoamine oxidase. Brit. Med. Bull.29, 116–120 (1973).
Tipton, K. F.: Monoamine oxidase. In: Handbook of Physiology, Section 7 (Endocrinology, Vol. VI. Adrenal gland), pp. 677–697 (1975).
Tipton, K. F., Houslay, M. D., Garrett, N. J.: Allotopic properties of human brain monoamine oxidase. Nature, New Biol.246, 213–214 (1973).
Tipton, K. F., Houslay, M. D., Mantle, T. J.: The nature and location of the multiple forms of monoamine oxidase. In: Monoamine oxidase and its inhibition (Knight, J., ed.). Amsterdam: North Holland. In press (1976).
Tissari, A.: 5-Hydroxytryptamine, 5-hydroxytryptophan decarboxylase and monoamine oxidase during fetal and postnatal development in the guinea pig. Acta physiol. scand.67, 1–80 (1966).
Trendelenburg, U., Draskoizy, P. R., Graefe, K. H.: The influence of intraneuronal monoamine oxidase on neuronal net uptake of noradrenalme and on sensitivity to noradrenaline. Adv. Biochem. Psychopharmacol.5, 371–378 (1972).
Utena, H., Kanamura, H., Suda, S., Nakamura, R., Machiyama, Y., Takahashi, R.: Studies on the regional distribution of the monoamine oxidase activity in the brains of schizophrenic patients. Proc. Jap. Acad.44, 1078–1083 (1968).
Vaccari, A., Maura, M., Marchi, M., Cugurra, F.: Development of monoamine oxidase in several tissues in the rat. J. Neurochem.19, 2453 to 2457 (1972).
Vogel, W. H., Orfei, V., Century, B.: Activities of enzymes involved in the formation and destruction of biogenic amines in various areas of human brain. J. Pharmac. exp. Ther.165, 195–203 (1969).
Weiner, N.: The distribution of monoamine oxidase and succinic oxidase in brain. J. Neurochem.6, 79–86 (1960).
Weiss, B. F., Roel, L. E., Munro, H. N., Wurtman, R. J.: L-Dopa polysomal aggregation and cerebral synthesis of protein. In: Aromatic amino acids in the brain (Wolstenholme, G. E. W., Fitzsimons, D. W., eds.), pp. 319 to 334. Amsterdam: North Holland. 1974.
Wilson, M. A., Cascarano, J.: Biochemical heterogeneity of rat liver mitochondria separated by rate zonal centrifugation. Biochem. J.129, 209–218 (1972).
Wurtman, R. J., Axelrod, J.: Control of enzymic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J. biol. Chem.241, 2301–2305 (1966).
Wyatt, R. J., Belmaker, R., Murphy, D. L.: Low platelet monoamine oxidase and vulnerability to schizophrenia. In: Modern problems of pharmacopsychiatry genetics and psychopharmacology (Mendlewicz, J., ed.), pp. 38–56. Basel: S. Karger. 1975.
Yang, H. Y. T., Neff, N. H.:β-phenylethylamine, a specific substrate for type B monoamine oxidase of brain. J. Pharmac. exp. Ther.187, 365 to 371 (1973).
Youdim, M. B. H.: Multiple forms of mitochondrial monoamine oxidase. Brit. Med. Bull.29, 120–122 (1973 a).
Youdim, M. B. H.: Heterogeneity of rat brain and liver mitochondrial monoamine oxidase: subcellular fractionation. Biochem. Soc. Trans.1, 1126–1127 (1973 b).
Youdim, M. B. H.: Heterogeneity of rat brain mitochondrial monoamine oxidase. Adv. Biochem. Psychopharmacol.11, 59–64 (1974).
Youdim, M. B. H.: Monoamine deaminating system in mammalian tissues. In: MTP International review of science (Biochemistry series Vol. 12) (Blaschko, H. K. F., ed.), pp. 169–211. London: Butterworths. 1975 a.
Youdim, M. B. H.: Monoamine oxidase: its inhibition. In: Modern problems of pharmacopsychiatry: genetics and psychopharmacology (Mendlewicz, J., ed.), pp. 65–89. Basel: Karger. 1975 b.
Youdim, M. B. H.: Assay and purification of brain monoamine oxidase. In: Methods in neurochemistry (Marks, N., Rodnight, R., eds.). New York: Plenum Press. In press (1975 c).
Youdim, M.B.H.: Monoamine oxidase active site: the binding to and titration of monoamine oxidase with (14C−) selective inhibitors. Br. J. Pharmac.56, 375 P (1976).
Youdim, M. B. H., Bonham Carter, S., Sandler, M., Hanington, E., Wilkinson, M.: Conjugation defect in tyramine sensitive migraine. Nature (Lond.)230, 127–128 (1971).
Youdim, M. B. H., Collins, G. G. S.: Properties and physiological significance of multiple forms of mitochondrial monoamine oxidase (MAO). In: Isozymes. II. Physiological function (Market, C. L., ed.), pp. 619 to 637. New York: Academic Press. 1975.
Youdim, M. B. H., Collins, G. G. S., Sandler, M.: Multiple forms of rat brain monoamine oxidase. Nature (Lond.)223, 626–628 (1969).
Youdim, M. B. H., Holman, B.: The nature of inhibition of cat brain mitochondrial monoamine oxidase by clorgyline. J. Neural Transm.37, 11–24(1975).
Youdim, M. B. H., Holzbauer, M., Woods, H. F.: Physico-chemical properties development and regulation of central peripheral monoamine oxidase activity. Adv. Biochem. Psychopharmacol.12, 11–28 (1974).
Youdim, M. B. H., Holzbauer, M.: Physiological aspects of the oxidative deamination of monoamines. In: Ciba Foundation Symposium No. 39. Monoamine oxidase and its inhibition (Knight, J., ed.). Amsterdam: North Holland. In press (1976).
Youdim, M. B. H., Marston, A.: The effect of iron deficiency in rat tissue monoamine oxidase. In preparation (1976).
Youdim, M. B. H., Woods, H. F., Mitchell, B., Grahame-Smith, D. G., Callender, S.: Human platelet monoamine oxidase activity in irondeficiency anaemia. Clin. Sci. Mol. Med.48, 289–295 (1975).
Zile, M. H.: Effect of thyroxine and related compounds on monoamine oxidase activity. Endocrinology66, 311–312 (1960).
Zile, M. H., Lardy, H.A.: Monoamine oxidase activity in liver of thyroid fed rats. Arch. Biochem.82, 411–421 (1959).
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dr.W. Birkmayer on the occasion of his 65th birthday.
Rights and permissions
About this article
Cite this article
Youdim, M.B.H., Holzbauer, M. Physiological and pathological changes in tissue monoamine oxidase activity. J. Neural Transmission 38, 193–229 (1976). https://doi.org/10.1007/BF01249439
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01249439